Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992
Stable expression of mammalian type A gamma-aminobutyric acid receptors in mouse cells: demonstration of functional assembly of benzodiazepine-responsive sitesK L Hadingham, P C Harkness, R M McKernan, et al.Proceedings of the National Academy of Sciences of the United States of America|August 18, 1999
theta, a novel gamma-aminobutyric acid type A receptor subunitT P Bonnert, R M McKernan, S Farrar, et al.Journal of Neurochemistry|June 1, 1996
Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypesS Grimwood, B Le Bourdellès, J R Atack, et al.Annals of the New York Academy of Sciences|July 22, 1999
Molecular and functional diversity of the expanding GABA-A receptor gene familyP J Whiting, T P Bonnert, R M McKernan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 15, 1997
Ligand-gated ion channel subunit partnerships: GABAA receptor alpha6 subunit gene inactivation inhibits delta subunit expressionA Jones, E R Korpi, R M McKernan, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2001
Loss of the major GABA(A) receptor subtype in the brain is not lethal in miceC Sur, K A Wafford, D S Reynolds, et al.Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.Nature Neuroscience|May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtypeR M McKernan, T W Rosahl, D S Reynolds, et al.Journal of Psychopharmacology (Oxford, England)|February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonistJ R Atack, D J Hallett, S Tye, et al.Pageof 6